<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940817-2-00258</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <TABLE>  <!-- PJG tableformat 4,L2,i1,s75,xs80,xs60,xs100 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=4 --> Table  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 --> 4&hyph;5._ <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Examples of Known Neuropathic Agents  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Site of attack <!-- PJG 007 0150 intable --> 1Neuropathology <!-- PJG 007 0150 intable --> 1Corresponding neurotoxicant <!-- PJG 007 0150 intable --> 1Disease or neurodegenerative condition <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=4 --> Neuron cell body <!-- PJG 007 0104 intable --> Neuronopathy <!-- PJG 007 0104 intable --> Methylmercury <!-- PJG 007 0104 intable --> Minamata disease. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=4 --> &blank; <!-- PJG 007 0104 intable -->  <!-- PJG 007 0170 intable --> l <!-- PJG 007 0104 intable --> A.E.T.T. <!-- PJG 007 0104 intable --> Ceroid lipofuscinoses. <!-- PJG 0012 frnewline --> &blank; <!-- PJG 007 0104 intable -->  <!-- PJG 007 0170 intable --> l <!-- PJG 007 0104 intable --> Quinolinic acid <!-- PJG 007 0104 intable --> Huntington's disease. <!-- PJG 0012 frnewline --> &blank; <!-- PJG 007 0104 intable -->  <!-- PJG 007 0170 intable --> l <!-- PJG 007 0104 intable --> 3-acetylpridine <!-- PJG 007 0104 intable --> Cerebellar ataxia. <!-- PJG 0012 frnewline --> &blank; <!-- PJG 007 0104 intable -->  <!-- PJG 007 0170 intable --> l <!-- PJG 007 0104 intable --> Aluminum <!-- PJG 007 0104 intable --> Alzheimer's disease. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=4 --> Nerve terminal <!-- PJG 007 0104 intable --> Neurodegeneration <!-- PJG 007 0104 intable --> MPTP <!-- PJG 007 0104 intable --> Parkinson's disease. <!-- PJG 0012 frnewline --> Schwann cell myelin <!-- PJG 007 0104 intable --> Myelinopathy <!-- PJG 007 0104 intable --> Lead Buckthorn toxin <!-- PJG 007 0104 intable --> Neuropathy of meta <!-- PJG 0034 unknown --> chro <!-- PJG 0034 unknown --> matic leuko <!-- PJG 0034 unknown --> dys <!-- PJG 0034 unknown --> trophy. <!-- PJG 0012 frnewline --> Central-peripheral distal axon <!-- PJG 007 0104 intable --> Distal axonopathy <!-- PJG 007 0104 intable --> Acrylamide Hexacarbons Carbon disulfide <!-- PJG 007 0104 intable --> Vitamin deficiency. <!-- PJG 0012 frnewline --> Central axons <!-- PJG 007 0104 intable --> Central axonopathy <!-- PJG 007 0104 intable --> Clioquinol <!-- PJG 007 0104 intable --> Subacute myelooptico-neuropathy. <!-- PJG 0012 frnewline --> Proximal axon  <!-- PJG 007 0104 intable --> Proximal axonopathy <!-- PJG 007 0104 intable --> B,B <!-- PJG 0020 minuteslatlong --> &rsquo;-imminodi-proprionitrile <!-- PJG 007 0104 intable --> Motor neuron disease. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            